Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
7 Cheap Biotech Stocks to Buy Now
These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
Upgrades 
Via Benzinga
What 5 Analyst Ratings Have To Say About IVERIC bio
Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings: 
Via Benzinga
IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch
Via Benzinga
Recap: IVERIC bio Q2 Earnings
  IVERIC bio (NASDAQ:ISEE) reported its Q2 earnings results on Tuesday, July 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For July 26, 2022
Companies Reporting Before The Bell • General Motors (NYSE:GM) is likely to report quarterly earnings at $1.30 per share on revenue of $34.59 billion. 
Via Benzinga
Short Volatility Alert: IVERIC bio, Inc.
On Wednesday, shares of IVERIC bio, Inc. (NASDAQ: ISEE) experienced volatile short activity. After the activity, the stock price went up +1.70% to $11.95. The overall sentiment for ISEE has been... 
Via Benzinga
3 Biotech Stock Picks From This Wedbush Analyst
While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June. 
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Alibaba, General Electric And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Redbox Entertainment Inc. (NASDAQ: RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday. 
Via Benzinga
Earnings Preview: IVERIC bio
IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that IVERIC bio will... 
Via Benzinga
Expert Ratings for IVERIC bio
IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
Upgrades 
Via Benzinga
IVERIC bio: Q1 Earnings Insights
IVERIC bio (NASDAQ:ISEE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IVERIC bio reported in-line EPS of... 
Via Benzinga
IVERIC bio Earnings Conference Call Is Coming Up, Here's What You Need To Know
IVERIC bio (NASDAQ:ISEE) will host a conference call at 08:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend IVERIC bio (ISEE) Conference Call Follow this link to access the... 
Via Benzinga
These Are Ten Small Cap Stocks With Strong Buy Recommendations
One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022
Upgrades For Procter & Gamble Co (NYSE:PG), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Procter & Gamble had an EPS of $1.66,... 
Via Benzinga
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
Earnings Outlook For IVERIC bio
IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Avenue Therapeutics (NASDAQ:ATXI... 
Via Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Avenue Therapeutics (NASDAQ:ATXI)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022
Upgrades For Enova International Inc (NYSE:ENVA), Maxim Group upgraded the previous rating of Hold to Buy. For the fourth quarter, Enova International had an EPS of $1.61,... 
Via Benzinga
Futures Tread Water Amid Peripheral Bond Rout As Key CPI Print Looms
U.S. index futures swung around in a volatile, illiquid overnight session, and at last check were flat despite traders' concerns about growing fireworks in the European bond market where Italian and... 
Via Talk Markets
7 A-Rated Biotechs to Buy for the Long Run
The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples. 
Via InvestorPlace
10 Biggest Price Target Changes For Wednesday
Needham raised DoorDash, Inc. (NASDAQ:DASH) pric... 
Via Benzinga
IVERIC bio, Inc. (ISEE) Q3 2021 Earnings Call Transcript
ISEE earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.